Agios Pharmaceuticals
AGIO
AGIO
218 hedge funds and large institutions have $1.76B invested in Agios Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 73 increasing their positions, 78 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 40
2% less funds holding
Funds holding: 223 → 218 (-5)
10% less capital invested
Capital invested by funds: $1.97B → $1.76B (-$206M)
Holders
218
Holding in Top 10
3
Calls
$10.6M
Puts
$11.1M
Top Buyers
| 1 | +$64M | |
| 2 | +$21.4M | |
| 3 | +$17.9M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$12.9M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$11M |
Top Sellers
| 1 | -$49.3M | |
| 2 | -$35.3M | |
| 3 | -$16.7M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$13.7M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
-$9.08M |